I maintain an active laboratory and translational research program focused on the role of RNA binding proteins in cancer and advancing basic science observations into meaningful clinical trials for patients.
Research interest is focused into three main areas: The first is a basic effort to understand the role post-transcriptional processes play in cancer initiation and progression. The second area of research interest takes advantage of my engineering background and appointment in the School of Engineering.
The third area of interest is the logical extension of the first two for a physician-scientist and involves the early phase clinical evaluation of novel cancer therapies. This includes the design and implementation of trials for newly diagnosed and recurrent malignant glioma that utilize biologically targeted strategies and includes non-invasive endpoints in the evaluation of a biological effect.